CYCC:Cyclacel Pharmaceuticals Inc * Snapshot | Charting | News | Options
*Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
$1.67 NASDAQ 9:15a ET
April 1 '24 		Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib... GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib's Potential as a Precision Medicine for Cancer
     GlobeNewswire
    Full Story →

    Headline News
    Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
    4:05p ET March 19 '24 GlobeNewswire
    Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results
    4:05p ET March 13 '24 GlobeNewswire
    Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
    9:15a ET March 7 '24 GlobeNewswire
    More News →
    Day  6.37%Week  20.85%Month  31.28%More Charting →
    April 16 '24. Markets Closed.
    Last $1.67
    Day change   6.37%$0.10
    Open $1.52
    Gap at open $0.05
    Previous close $1.57
    Trading volume 48,891
    10 Day avg vol. 22,484
    Shares out. 1.3Mil
    Market cap. $2.2Mil
    Trading activity Above Avg.
    Previous data from yesterday, April 15 '24.

    Historical Price Performance
    3 month   20.10% 
    6 month   82.66% 
    1 year   81.08% 
    2 year   94.57% 

    Earnings
    Previous 12m -$26.72
    Next 12m Estimate -$13.38
    P/E ratio 0.1x
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.